These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors. Al-Sabah S, Donnelly D. Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080 [Abstract] [Full Text] [Related]
9. Met-204 and Tyr-205 are together important for binding GLP-1 receptor agonists but not their N-terminally truncated analogues. López de Maturana R, Treece-Birch J, Abidi F, Findlay JB, Donnelly D. Protein Pept Lett; 2004 Feb; 11(1):15-22. PubMed ID: 14965274 [Abstract] [Full Text] [Related]
10. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells. Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B. J Biol Chem; 1993 Sep 15; 268(26):19650-5. PubMed ID: 8396143 [Abstract] [Full Text] [Related]
11. Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain. Runge S, Thøgersen H, Madsen K, Lau J, Rudolph R. J Biol Chem; 2008 Apr 25; 283(17):11340-7. PubMed ID: 18287102 [Abstract] [Full Text] [Related]
12. Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor. Underwood CR, Garibay P, Knudsen LB, Hastrup S, Peters GH, Rudolph R, Reedtz-Runge S. J Biol Chem; 2010 Jan 01; 285(1):723-30. PubMed ID: 19861722 [Abstract] [Full Text] [Related]
13. Glucagon-like peptide-1 receptor ligand interactions: structural cross talk between ligands and the extracellular domain. West GM, Willard FS, Sloop KW, Showalter AD, Pascal BD, Griffin PR. PLoS One; 2014 Jan 01; 9(9):e105683. PubMed ID: 25180755 [Abstract] [Full Text] [Related]
14. The glucagon-like peptide-1 receptor binding site for the N-terminus of GLP-1 requires polarity at Asp198 rather than negative charge. López de Maturana R, Donnelly D. FEBS Lett; 2002 Oct 23; 530(1-3):244-8. PubMed ID: 12387900 [Abstract] [Full Text] [Related]
15. Oxyntomodulin and glucagon-like peptide-1 differentially regulate murine food intake and energy expenditure. Baggio LL, Huang Q, Brown TJ, Drucker DJ. Gastroenterology; 2004 Aug 23; 127(2):546-58. PubMed ID: 15300587 [Abstract] [Full Text] [Related]
17. Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Neidigh JW, Fesinmeyer RM, Prickett KS, Andersen NH. Biochemistry; 2001 Nov 06; 40(44):13188-200. PubMed ID: 11683627 [Abstract] [Full Text] [Related]
18. Stable expression of the rat GLP-I receptor in CHO cells: activation and binding characteristics utilizing GLP-I(7-36)-amide, oxyntomodulin, exendin-4, and exendin(9-39). Fehmann HC, Jiang J, Schweinfurth J, Wheeler MB, Boyd AE, Göke B. Peptides; 1994 Nov 06; 15(3):453-6. PubMed ID: 7937318 [Abstract] [Full Text] [Related]
19. Molecular cloning of the helodermin and exendin-4 cDNAs in the lizard. Relationship to vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide and glucagon-like peptide 1 and evidence against the existence of mammalian homologues. Pohl M, Wank SA. J Biol Chem; 1998 Apr 17; 273(16):9778-84. PubMed ID: 9545315 [Abstract] [Full Text] [Related]
20. Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain. Runge S, Schimmer S, Oschmann J, Schiødt CB, Knudsen SM, Jeppesen CB, Madsen K, Lau J, Thøgersen H, Rudolph R. Biochemistry; 2007 May 15; 46(19):5830-40. PubMed ID: 17444618 [Abstract] [Full Text] [Related] Page: [Next] [New Search]